申请人:Ibrahim Prabha N.
公开号:US20120165329A1
公开(公告)日:2012-06-28
Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one of Fms protein kinase or Kit protein kinase. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of Fms protein kinases and/or Kit protein kinases, including rheumatoid arthritis, osteoarthritis, osteoporosis, peri-prosthetic osteolysis, systemic sclerosis, demyelinating disorders, multiple sclerosis, Charcot Marie Tooth syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ulcerative colitis, Crohn's disease, immune thrombocytopenic purpura, myelopreparation for autologous transplantation, transplant rejection, nephritis, nephropathy, type I diabetes, acute pain, inflammatory pain, neuropathic pain, breast cancer, prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, gliomas, glioblastomas, neurofibromatosis, osteolytic bone metastases, and giant cell tumors.
本文描述了化合物及其盐、制剂、共轭物、衍生物、形式和用途。在某些方面和实施例中,所述化合物或其盐、制剂、共轭物、衍生物、形式至少对Fms蛋白激酶或Kit蛋白激酶之一具有活性。还描述了使用它们治疗与Fms蛋白激酶和/或Kit蛋白激酶活性相关的疾病和病况的方法,包括风湿性关节炎、骨关节炎、骨质疏松症、人工关节周围骨质疏松症、系统性硬化症、脱髓鞘疾病、多发性硬化症、Charcot Marie Tooth综合症、肌萎缩侧索硬化症、阿尔茨海默病、帕金森病、溃疡性结肠炎、克罗恩病、免疫性血小板减少性紫癜、自体移植的骨髓准备、移植排斥反应、肾炎、肾病、1型糖尿病、急性疼痛、炎症性疼痛、神经病性疼痛、乳腺癌、前列腺癌、胰腺癌、肺癌、卵巢癌、胶质瘤、胶质母细胞瘤、神经纤维瘤病、溶骨性骨转移和巨细胞瘤。